Keel Point’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.71M | Sell |
36,633
-2,754
| -7% | -$322K | 0.28% | 56 |
|
|
2026
Q1 | $4.74M | Sell |
39,387
-12,184
| -24% | -$1.41M | 0.31% | 48 |
|
|
2025
Q4 | $5.43M | Sell |
51,571
-9,252
| -15% | -$868K | 0.33% | 50 |
|
|
2025
Q3 | $5.1M | Buy |
60,823
+1,652
| +3% | +$136K | 0.31% | 51 |
|
|
2025
Q2 | $4.68M | Buy |
59,171
+6,841
| +13% | +$544K | 0.31% | 57 |
|
|
2025
Q1 | $4.7M | Buy |
52,330
+11,303
| +28% | +$1.06M | 0.36% | 48 |
|
|
2024
Q4 | $4.08M | Sell |
41,027
-228
| -0.6% | -$23.5K | 0.33% | 57 |
|
|
2024
Q3 | $4.68M | Buy |
41,255
+1,622
| +4% | +$193K | 0.39% | 47 |
|
|
2024
Q2 | $4.53M | Buy |
39,633
+897
| +2% | +$116K | 0.41% | 46 |
|
|
2024
Q1 | $5.11M | Buy |
38,736
+1,357
| +4% | +$167K | 0.53% | 33 |
|
|
2023
Q4 | $4.08M | Sell |
37,379
-361
| -1% | -$37.5K | 0.49% | 39 |
|
|
2023
Q3 | $3.89M | Sell |
37,740
-1,425
| -4% | -$154K | 0.53% | 34 |
|
|
2023
Q2 | $4.52M | Sell |
39,165
-2,216
| -5% | -$252K | 0.6% | 28 |
|
|
2023
Q1 | $4.4M | Buy |
41,381
+32,767
| +380% | +$3.54M | 0.64% | 26 |
|
|
2022
Q4 | $956K | Buy |
8,614
+748
| +10% | +$76.5K | 0.15% | 110 |
|
|
2022
Q3 | $677K | Sell |
7,866
-38
| -0.5% | -$3.39K | 0.12% | 116 |
|
|
2022
Q2 | $705K | Buy |
7,904
+992
| +14% | +$87.9K | 0.11% | 121 |
|
|
2022
Q1 | $567K | Buy |
6,912
+1,191
| +21% | +$93.9K | 0.09% | 138 |
|
|
2021
Q4 | $438K | Buy |
5,721
+469
| +9% | +$37.4K | 0.05% | 167 |
|
|
2021
Q3 | $394K | Buy |
5,252
+221
| +4% | +$16.8K | 0.05% | 165 |
|
|
2021
Q2 | $391K | Sell |
5,031
-132
| -3% | -$9.82K | 0.04% | 174 |
|
|
2021
Q1 | $380K | Buy |
5,163
+524
| +11% | +$38.7K | 0.04% | 181 |
|
|
2020
Q4 | $362K | Buy |
4,639
+111
| +2% | +$8.49K | 0.03% | 179 |
|
|
2020
Q3 | $358K | Buy |
+4,528
| New | +$355K | 0.03% | 165 |
|
|
2016
Q4 | – | Sell |
-3,672
| Closed | -$219K | – | 163 |
|
|
2016
Q3 | $219K | Sell |
3,672
-42
| -1% | -$2.46K | 0.08% | 121 |
|
|
2016
Q2 | $204K | Buy |
+3,714
| New | +$198K | 0.09% | 127 |
|
|
2015
Q3 | – | Sell |
-4,073
| Closed | -$226K | – | 107 |
|
|
2015
Q2 | $226K | Buy |
+4,073
| New | +$228K | 0.11% | 91 |
|
Other funds holding MRK
Keel Point's MRK Position: Q2 2026 in Review
Keel Point reduced its Merck (MRK) stake by 7% in Q2 2026, selling an estimated $322K and leaving 36,633 shares worth $4.71M. The position accounts for 0.28% of the portfolio, ranked #56.
Keel Point first reported a position in MRK in Q2 2015 and has held it in 27 quarters since. The position peaked at $5.43M in Q4 2025. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Keel Point held 36,633 shares of Merck worth $4.71M as of Q2 2026.
- Keel Point sold 2,754 Merck shares in Q2 2026, an estimated $322K.
- Merck made up 0.28% of Keel Point's portfolio in Q2 2026, its #56 holding.
- Keel Point first reported a position in Merck in Q2 2015 and has held it in 27 quarters since.
- Keel Point's Merck position peaked at $5.43M in Q4 2025.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Keel Point's 13F filing for Q2 2026, filed 14 Aug 2026.